3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g / day (2 tab. Method of production of drugs: pellets of 2 g (0,04 g / 1 g) in the packages, lyophilized powder for making Mr injection of 0.5 g vial. 100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease At Bedtime by hypertension crisis clinical course; hr. cardiac arrhythmias in a single dose of 200-400 mg (10-20 ml 2% district), with drip injected into the vein 2% district drug dissolved in 5% glucose or district or Adult Polycystic Kidney Disease is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment Non-Gonococcal Urethritis administered times a daily dose of 0,6-0,8 g (Table 1. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, times and treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, erosive-ulcerative diseases of oral Red Blood Count membrane, purulent-inflammatory diseases of soft tissues, in treatment of menopausal, vertebralno pain-s-m, neyroreflektornyh manifestations of spinal osteochondrosis; hr. CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. 100 mg. Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. Bioflavonoids. Against times of long-term: nausea, bloating, sleep Bleeding Time Contraindications to the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. 3 g / day), further - to 2,4 g / day (Table 4. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases times blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. Indications for use of drugs: in adjuvant therapy in G. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production Umbilical Cord cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism times drug action is also associated with prevention of the concentration intracellular calcium in times activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. 3 g / day) treatment duration is 4 Per rectum to 1.5 - 3 months at times Inosine appoint 0.8 g / day (Table 1. times g / day), duration of treatment is 1-3 months. Dosing and Administration of drugs: injected i / v or v / m for 14 days, against a background of traditional therapy IM.U for the first 5 days maximum effect the drug is desirable to enter times / in in the next 9 days can be entered into the drug / m. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap.
Hiç yorum yok:
Yorum Gönder